1
|
Lee SH, Chang PH, Chen PT, Lu CH, Hung YS,
Tsang NM, Hung CY, Chen JS, Hsu HC, Chen YY and Chou WC:
Association of time interval between cancer diagnosis and
initiation of palliative chemotherapy with overall survival in
patients with unresectable pancreatic cancer. Cancer Med.
8:3471–3478. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Skau Rasmussen L, Vittrup B, Ladekarl M,
Pfeiffer P, Karen Yilmaz M, Østergaard Poulsen L, Østerlind K,
Palnæs Hansen C, Bau Mortensen M, Viborg Mortensen F, et al: The
effect of postoperative gemcitabine on overall survival in patients
with resected pancreatic cancer: A nationwide population-based
Danish register study. Acta Oncol. 58:864–871. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Elaileh A, Saharia A, Potter L, Baio F,
Ghafel A, Abdelrahim M and Heyne K: Promising new treatments for
pancreatic cancer in the era of targeted and immune therapies. Am J
Cancer Res. 9:1871–1888. 2019.PubMed/NCBI
|
4
|
Mitschke J, Burk UC and Reinheckel T: The
role of proteases in epithelial-to-mesenchymal cell transitions in
cancer. Cancer Metastasis Rev. 38:431–444. 2019. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hu X, Zhai Y, Kong P, Cui H, Yan T, Yang
J, Qian Y, Ma Y, Wang F, Li H, et al: FAT1 prevents epithelial
mesenchymal transition (EMT) via MAPK/ERK signaling pathway in
esophageal squamous cell cancer. Cancer Lett. 397:83–93. 2017.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam
D, Lee J, Lee SG, Yang WM, Um JY, et al: Ginkgolic acid inhibits
invasion and migration and TGF-β-induced EMT of lung cancer cells
through PI3K/Akt/mTOR inactivation. J Cell Physiol. 232:346–354.
2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yang Y, Bai YS and Wang Q: CDGSH Iron
Sulfur domain 2 activates proliferation and EMT of pancreatic
cancer cells via Wnt/β-catenin pathway and has prognostic value in
human pancreatic cancer. Oncol Res. 25:605–615. 2017. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kleszcz R: The canonical Wnt pathway.
Postepy Biochem. 65:183–192. 2019.(In Polish). View Article : Google Scholar : PubMed/NCBI
|
9
|
Lin Y, Dong C and Zhou BP: Epigenetic
regulation of EMT: The Snail story. Curr Pharm Des. 20:1698–1705.
2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Huang X, Zhi X, Gao Y, Ta N, Jiang H and
Zheng J: LncRNAs in pancreatic cancer. Oncotarget. 7:57379–57390.
2016.PubMed/NCBI
|
12
|
Yang J, Ye Z, Mei D, Gu H and Zhang J:
Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating
miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
Cancer Manag Res. 11:4209–4221. 2019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang
Q and Wu H: LncRNA H19/miR-194/PFTK1 axis modulates the cell
proliferation and migration of pancreatic cancer. J Cell Biochem.
120:3874–3886. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang ZK, Yang L, Wu LL, Mao H, Zhou YH,
Zhang PF and Dai GH: Long non-coding RNA LINC00261 sensitizes human
colon cancer cells to cisplatin therapy. Braz J Med Biol Res.
51:e67932017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yu Y, Li L, Zheng Z, Chen S, Chen E and Hu
Y: Long non-coding RNA linc00261 suppresses gastric cancer
progression via promoting Slug degradation. J Cell Mol Med.
21:955–967. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Shi J, Ma H, Wang H, Zhu W, Jiang S, Dou R
and Yan B: Overexpression of LINC00261 inhibits non-small cell lung
cancer cells progression by interacting with miR-522-3p and
suppressing Wnt signaling. J Cell Biochem. 120:18378–18387.
2019.PubMed/NCBI
|
17
|
Yan D, Liu W, Liu Y and Luo M: LINC00261
suppresses human colon cancer progression via sponging miR-324-3p
and inactivating the Wnt/β-catenin pathway. J Cell Physiol.
234:22648–22656. 2019. View Article : Google Scholar : PubMed/NCBI
|
18
|
Liu H, Yin J, Wang H, Jiang G, Deng M,
Zhang G, Bu X, Cai S, Du J and He Z: FOXO3a modulates WNT/β-catenin
signaling and suppresses epithelial-to-mesenchymal transition in
prostate cancer cells. Cell Signal. 27:510–518. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yao S, Fan LY and Lam EW: The FOXO3-FOXM1
axis: A key cancer drug target and a modulator of cancer drug
resistance. Semin Cancer Biol. 50:77–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Li J, Yang R, Dong Y, Chen M, Wang Y and
Wang G: Knockdown of FOXO3a induces epithelial-mesenchymal
transition and promotes metastasis of pancreatic ductal
adenocarcinoma by activation of the β-catenin/TCF4 pathway through
SPRY2. J Exp Clin Cancer Res. 38:382019. View Article : Google Scholar : PubMed/NCBI
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Iyer S, Ambrogini E, Bartell SM, Han L,
Roberson PK, de Cabo R, Jilka RL, Weinstein RS, O'Brien CA,
Manolagas SC and Almeida M: FOXOs attenuate bone formation by
suppressing Wnt signaling. J Clin Invest. 123:3409–3419. 2013.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Previdi MC, Carotenuto P, Zito D, Pandolfo
R and Braconi C: Noncoding RNAs as novel biomarkers in pancreatic
cancer: What do we know? Future Oncol. 13:443–453. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wang H, Sha L, Huang L, Yang S, Zhou Q,
Luo X and Shi B: LINC00261 functions as a competing endogenous RNA
to regulate BCL2L11 expression by sponging miR-132-3p in
endometriosis. Am J Transl Res. 11:2269–2279. 2019.PubMed/NCBI
|
26
|
Cheng D, Jiang S, Chen J, Li J, Ao L and
Zhang Y: Upregulated long noncoding RNA Linc00261 in pre-eclampsia
and its effect on trophoblast invasion and migration via regulating
miR-558/TIMP4 signaling pathway. J Cell Biochem. 120:13243–13253.
2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lin K, Jiang H, Zhuang SS, Qin YS, Qiu GD,
She YQ, Zheng JT, Chen C, Fang L and Zhang SY: Long noncoding RNA
LINC00261 induces chemosensitization to 5-fluorouracil by mediating
methylation-dependent repression of DPYD in human esophageal
cancer. FASEB J. 33:1972–1988. 2019. View Article : Google Scholar : PubMed/NCBI
|
28
|
Fang Q, Sang L and Du S: Long noncoding
RNA LINC00261 regulates endometrial carcinoma progression by
modulating miRNA/FOXO1 expression. Cell Biochem Funct. 36:323–330.
2018. View
Article : Google Scholar : PubMed/NCBI
|
29
|
Cai W, Xu Y, Yin J, Zuo W and Su Z:
miR-552-5p facilitates osteosarcoma cell proliferation and
metastasis by targeting WIF1. Exp Ther Med. 17:3781–3788.
2019.PubMed/NCBI
|